Calcium and vitamin D supplementation and loss of bone mineral density in women undergoing breast cancer therapy
This 2013 systematic review analyzed 16 trials assessing calcium and/or vitamin D supplementation in women undergoing breast cancer therapy. The findings indicate that supplementation with calcium (500–1500 mg) and vitamin D (200–1000 IU) did not prevent bone mineral density (BMD) loss in these patients. The study highlights the need for
June 26, 2025
No Comments